Jerome Stevens Pharmaceuticals, renowned generics manufacturer, selects XFP MES from Elan Software

XFP warehousing and electronic batch record software will enhance quality and accelerate Jerome Stevens’ expansion.
By: Cecile Morel
Dec. 11, 2008 - PRLog -- Elan Software Systems, a leading provider of Manufacturing Execution System (MES) software solutions, with a customer portfolio that includes companies such as Baxter, Takeda, sanofi aventis, Rochas and Yves Rocher, announced today that Jerome Stevens Pharmaceuticals, a renowned generics manufacturer, home of UNITHROID®, the country’s first FDA-Approved levothyroxine product, has chosen XFP MES. The MES software suite will help JSP with its continued expansion and eventually transform its manufacturing operations into a near paperless production site, benefiting from increased efficiency and enhanced quality.

The current solution deployment focuses specifically on warehousing and inventory control, with the usage of a bar-coding system throughout the facility. It will be followed in early 2009 with the implementation of an electronic batch record across all product lines, accelerating the batch release process.  

Clearest manufacturing software package of the market
Over the years, JSP has transformed its business from an OTC company to a prescription drug manufacturer. Nonetheless, JSP has kept the same approach to its operational strategy, an approach that promotes innovation, quality and discipline.

“Jerome Stevens Pharmaceuticals is experiencing a period of rapid growth and expansion. And our key objective is to always maintain the high quality standards that we have always provided.” explains Daniel Akeson, Quality Assurance Manager at JSP. “We came to a point where we could not increase our business without real time inventory status, optimized material flows or electronic batch reviews. We truly believed a MES system was the right solution for the current challenges facing our business. XFP from Elan Software was the most comprehensive and user-friendly MES package we saw that met all regulatory requirements. These requirements are very unique and critical to our industry.”

Enhanced quality and increased productivity
With the deployment of XFP MES, JSP aims to modernize its manufacturing facility. The advantages of the MES system include higher traceability through the use of electronic signatures, security and bar-coding, improved process repeatability due to stricter control of key process parameters, simpler and faster review, cross-referencing as well as the electronic storage of batch information.

“As a family-owned business that has always put emphasis on product quality, it was critical for JSP to successfully manage their growth without comprising quality in any way.” said Ken Strum, Sales Director at Elan Software. “Not only does XFP-MES provide the complete visibility and procedural control, the exact as-built history and the batch traceability, XFP also provides JSP with the fast and efficient batch release needed to provide enhanced quality and better productivity. The result? Highly satisfied customers. ”


Elan Software Systems is a leading provider of Manufacturing Execution System (MES) dedicated to Life Sciences.

For over 20 years, Elan Software has been providing regulated industries with advanced MES solutions to improve production efficiency and effectiveness. The XFP Suite from Elan Software brings manufacturing intelligence throughout the plant. It provides production visibility and control throughout the enterprise by optimizing the production cycle from raw material delivery to end product shipment in compliance with 21CFR part 11 and ISA 88/95. The XFP suite promotes paperless manufacturing and provides life science manufacturers with advanced modules for warehousing, weighing and dispensing, work instructions and electronic batch record.

Seven of the top ten health care companies have trusted Elan’s MES software. Elan customers include Abbott, AstraZeneca, Baxter, BestSweet, Famar, JSP, Ipsen, LFB Merck, sanofi-aventis, Rochas, Takeda and UCB.

For more information:

About Jerome Stevens Pharmaceuticals

Jerome Stevens Pharmaceuticals, Inc. is a family owned and operated pharmaceutical manufacturer of prescription tablet and capsule formulations.
Home of UNITHROID®, the country’s FIRST FDA-Approved levothyroxine product, “JSP” has been manufacturing generics since 1979 with the kind of quality that only a family owned and operated business could produce.  JSP maintains the same quality that has been a staple of its history, having never received a recall on ANY product. This stellar history of product quality continues to allow JSP to manufacture the safest products on the market.

For more information:

Like PRLog?
Click to Share